Sentry Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-193
| Closed | -$131K | – | 237 |
|
|
2025
Q4 | $131K | Hold |
193
| – | – | 0.09% | 196 |
|
|
2025
Q3 | $122K | Sell |
193
-46
| -19% | -$27.9K | 0.08% | 207 |
|
|
2025
Q2 | $129K | Hold |
239
| – | – | 0.07% | 239 |
|
|
2025
Q1 | $91K | Sell |
239
-71
| -23% | -$30.8K | 0.06% | 267 |
|
|
2024
Q4 | $128K | Sell |
310
-51
| -14% | -$22.4K | 0.06% | 258 |
|
|
2024
Q3 | $182K | Hold |
361
| – | – | 0.08% | 232 |
|
|
2024
Q2 | $176K | Sell |
361
-74
| -17% | -$37.1K | 0.08% | 222 |
|
|
2024
Q1 | $235K | Hold |
435
| – | – | 0.09% | 210 |
|
|
2023
Q4 | $241K | Sell |
435
-47
| -10% | -$22.1K | 0.1% | 200 |
|
|
2023
Q3 | $211K | Sell |
482
-66
| -12% | -$32.9K | 0.1% | 205 |
|
|
2023
Q2 | $275K | Hold |
548
| – | – | 0.1% | 203 |
|
|
2023
Q1 | $274K | Sell |
548
-6
| -1% | -$2.87K | 0.11% | 202 |
|
|
2022
Q4 | $226K | Sell |
554
-17
| -3% | -$6.6K | 0.1% | 225 |
|
|
2022
Q3 | $186K | Hold |
571
| – | – | 0.09% | 240 |
|
|
2022
Q2 | $200K | Sell |
571
-111
| -16% | -$45.3K | 0.09% | 229 |
|
|
2022
Q1 | $373K | Sell |
682
-147
| -18% | -$77.3K | 0.12% | 178 |
|
|
2021
Q4 | $546K | Buy |
829
+56
| +7% | +$35.2K | 0.14% | 165 |
|
|
2021
Q3 | $481K | Sell |
773
-113
| -13% | -$75.9K | 0.14% | 161 |
|
|
2021
Q2 | $560K | Hold |
886
| – | – | 0.14% | 162 |
|
|
2021
Q1 | $434K | Sell |
886
-4,233
| -83% | -$2.12M | 0.12% | 177 |
|
|
2020
Q4 | $2.56M | Hold |
5,119
| – | – | 0.13% | 163 |
|
|
2020
Q3 | $2.01M | Hold |
5,119
| – | – | 0.11% | 175 |
|
|
2020
Q2 | $1.69M | Buy |
5,119
+16
| +0.3% | +$4.63K | 0.1% | 196 |
|
|
2020
Q1 | $1.24M | Hold |
5,103
| – | – | 0.09% | 199 |
|
|
2019
Q4 | $1.33M | Hold |
5,103
| – | – | 0.08% | 249 |
|
|
2019
Q3 | $1.39M | Hold |
5,103
| – | – | 0.09% | 226 |
|
|
2019
Q2 | $1.41M | Hold |
5,103
| – | – | 0.09% | 230 |
|
|
2019
Q1 | $1.14M | Sell |
5,103
-453
| -8% | -$93.5K | 0.08% | 246 |
|
|
2018
Q4 | $1.03M | Sell |
5,556
-145
| -3% | -$29.7K | 0.07% | 258 |
|
|
2018
Q3 | $1.42M | Hold |
5,701
| – | – | 0.09% | 234 |
|
|
2018
Q2 | $1.24M | Sell |
5,701
-635
| -10% | -$131K | 0.08% | 255 |
|
|
2018
Q1 | $1.21M | Sell |
6,336
-609
| -9% | -$112K | 0.07% | 276 |
|
|
2017
Q4 | $1.09M | Buy |
+6,945
| New | +$1.09M | 0.06% | 309 |
|
Other funds holding IDXX
Sentry Investment Management's IDXX Position: Q1 2026 in Review
Sentry Investment Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 193 shares — an estimated $131K sold.
Sentry Investment Management first reported a position in IDXX in Q4 2017 and held it in 33 quarters. The position peaked at $2.56M in Q4 2020. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Sentry Investment Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Sentry Investment Management sold 193 Idexx Laboratories shares in Q1 2026, an estimated $131K.
- Sentry Investment Management first reported a position in Idexx Laboratories in Q4 2017 and held it in 33 quarters.
- Sentry Investment Management's Idexx Laboratories position peaked at $2.56M in Q4 2020.
- 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.